BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $9

Benzinga Newsdesk www.benzinga.com Positive 72.4%

Neg 0% Neu 0% Pos 72.4%

BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $8 to $9.

Comments

No comments yet. Be the first!